Video scenes shots:
Watch the video:
Other videos by this author:
 |
Breast Reconstruction Technique Posted by: OncologyReport
Video duration: 153 seconds A technique using an acellular dermal matrix allow for an earlier implant, less scarring, and more natural shape, Dr. Michael Rosenberg tells GMNN's Michele Sullivan discusses a technique for breast reconstruction after breast cancer surgery. |
 |
20 Years of Melanoma Updates Posted by: OncologyReport
Video duration: 244 seconds Dr. Hubert T. Greenway, Jr., and Terry L. Barrett reflect on their founding of the Melanoma: Annual Cutaneous Malignancy Update conference 20 years ago. They discuss key advances in the field over the past two decades and make projections for melanoma treatment in the future. (GMNNs Doug Brunk reports.) |
 |
Bisphosphonates May Reduce Breast Cancer Risk Posted by: OncologyReport
Video duration: 209 seconds Dr. Rowan Chlebowski of Harbor-UCLA's medical center discusses two studies that suggest bisphophonates can lower risk to breast cancer. |
 |
Multiple Myeloma in the Elderly Posted by: OncologyReport
Video duration: 210 seconds In the VISTA trial, the Spanish Myeloma Group created an induction regimen of bortezomib, melphalan, and prednisone that elderly patients could tolerate. This year the group took that regimen a step further. |
 |
CML Treatment: Old Drug, New Name Posted by: OncologyReport
Video duration: 258 seconds There's a new old drug for chronic myeloid leukemia, and it seems to work in patients who don't respond to any of the approved therapies for this disease. Dr. Jorge Cortes discusses the potential of omacetaxine mepesuccinate at the annual meeting of the American Society of Hematology. |
 |
First-Line Lymphoma Treatments Posted by: OncologyReport
Video duration: 207 seconds Bendamustine plus rituximab has the potential to replace standard CHOP chemotherapy plus rituximab in the first-line treatment of advanced lymphomas. Dr. Mathias J. Rummel discusses data presented at the annual meeting of the American Society of Hematology. |
 |
New Recommendations for HPV Vaccination Posted by: OncologyReport
Video duration: 108 seconds Dr. Sandra Fryhofer discusses ACIP's recommendations on the use of bivalent HPV vaccine in females and quadrivalent HPV vaccine in males. |
![Melanoma: \](http://img.youtube.com/vi/oyOUbmCmB0Q&feature=youtube_gdata/2.jpg "Melanoma: \") |
Melanoma: 'D' is for Darkness? Posted by: OncologyReport
Video duration: 186 seconds Dr. Stuart Goldsmith discusses why he thinks lesion darkness would make a better critrion for identifying early melanomas than the 6-mm diameter cutoff in the ABCDE criteria currently used by patients and doctors. Kerri Wachter of the Global Medical News Network (GMNN) reports from the American Academy of Dermatology's Academy 2009 meeting. |
 |
Lymphoma and Biologics Posted by: OncologyReport
Video duration: 215 seconds Dr. Joel Gelfand discusses research concerning the use of biologics and lymphoma risk. Kerri Wachter of the Global Medical News Network (GMNN) reports from the American Academy of Dermatology's Academy 2009 meeting in Boston. |
 |
Expert Perspective: Lung Cancer Meeting Posted by: OncologyReport
Video duration: 283 seconds Dr. Roy S. Herbst reflects on the most clinically relevant studies presented at the world conference of the International Association for the Study of Lung Cancer. Dr. Herbst is chief of Thoracic Head and Neck Medical Oncology at M. D. Anderson Cancer Center. He is also associate editor of the Oncology Report, an Elsevier publication. GMNN's Bob Finn reports. |
 |
Iloprost Posted by: OncologyReport
Video duration: 106 seconds Endobronchial dysplasia significantly improved in former smokees who received oral iloprost during a phase II trial, says study investigator Dr. Robert Keith. Bob Finn of the Global Medical News Network (GMNN) reports from the World Conference on Lung Cancer in San Francisco. |
 |
Sputum Sample & Lung Cancer Posted by: OncologyReport
Video duration: 159 seconds An investigational device can discriminate normal cells from cancerous cells in sputum with 90% sensitivity and near 100% specificity, according to its manufacturer, VisionGate, Inc. Bob Finn of the Global Medical News Network (GMNN) reports from the World Conference on Lung Cancer in San Francisco. |
 |
Staging System Posted by: OncologyReport
Video duration: 289 seconds A revolutionary new staging system for lung cancer will unite clinicians from different specialties and nations in characterizing tumor characteristics, node involvement, and metastasis, says Dr. Peter Goldstraw. Betsy Bates of the Global Medical News Network (GMNN) reports from the World Conference on Lung Cancer in San Francisco. |
 |
Ofatumumab Posted by: OncologyReport
Video duration: 185 seconds Dr. William Wierda discusses ofatumumab, an investigational monoclonal antibody that targets B cells and has been studied in the treatment of chronic lymphocytic leukemia. Mitchel Zoler of the Global Medical News Network (GMNN) reports from the annual congress of the European Hematology Association in Berlin |
 |
Romiplostim Posted by: OncologyReport
Video duration: 153 seconds Dr. Mathias Rummel discusses findings that treating immune thrombocytopenic patients with the platelet-stimulator romiplostim significantly cuts the rate of splenectomy, compared with usual care. Mitchel Zoler of the Global Medical News Network (GMNN) reports from the annual congress of the European Hematology Association in Berlin. |
 |
Panitumumab Posted by: OncologyReport
Video duration: 236 seconds Dr. Edith Mitchell describes a significant reduction in skin toxicity when a skin care regimen and oral antibiotic were given before panitumumab treatment for cancer. Damian McNamara of the Global Medical News Network (GMNN) reports from the annual meeting of the American Society of Clinical Oncology in Orlando. |
 |
Survivors of Childhood Cancers Posted by: OncologyReport
Video duration: 209 seconds Dr. Paul Nathan discusses data that suggest few adult survivors of childhood cancer get routine screening and surveillance for second cancers. Damian McNamara of the Global Medical News Network (GMNN) reports from the annual meeting of the American Society of Clinical Oncology in Orlando. |
 |
Trastuzumab and Gastric Cancer Posted by: OncologyReport
Video duration: 182 seconds Dr. Eric Van Cutsem discusses how trastuzumab may be able to provide a significant survival advantage for gastric cancer patients whose tumors carry the HER2 receptor. Neil Osterweil of Global Medical News Network (GMNN) reports from the annual meeting of the American Society of Clinical Oncology in Orlando, Florida. |
 |
Pemetrexed Posted by: OncologyReport
Video duration: 223 seconds Dr. Chandra P. Belani reports that maintenance therapy with pemetrexed significantly improves overall survival in advanced non-small cell lung cancer. Damian McNamara of the Global Medical News Network (GMNN) reports from the annual meeting of the American Society of Clinical Oncology in Orlando. |
 |
Erlotinib in Lung Cancer Posted by: OncologyReport
Video duration: 185 seconds Dr. Vincent A. Miller describes study results that suggest the addition of erlotinib to bevacizumab treatment for advanced non-small cell lung cancer extends progression-free survival compared with bevacizumab alone. Damian McNamara of the Global Medical News Network (GMNN) reports from the annual meeting of the American Society of Clinical Oncology in Orlando. |
 |
HRT and Lung Cancer Posted by: OncologyReport
Video duration: 163 seconds Dr. Rowan Chlebowski says his findings suggest an increased risk of non-small cell lung cancer associated with combination hormone therapy in a secondary analysis of data from the Women's Health Initiative study. Damian McNamara of the Global Medical News Network (GMNN) reports from the annual meeting of the American Society of Clinical Oncology in Orlando. |
 |
Bevacizumab Fails to Improve 3-Year Survival in Early Colon Cancer Posted by: OncologyReport
Video duration: 270 seconds Dr. Norman Wolmark explains his team's large, much-anticipated study showing that bevacizumab failed to make a significant improvement in disease-free survival at 3 years for early-stage colon cancer. Dr. Wolmark, chairman of Human Oncology, Allegheny General Hospital in Pittsburgh, presented the findings at the annual meeting of the American Society of Clinical Oncology. |
 |
SLN Biopsy Posted by: OncologyReport
Video duration: 269 seconds Dr. Kelly K. Hunt discusses findings that sentinel lymph node (SLN) biopsy when done after --rather than before--neoadjuvant chemotherapy cuts the need for axillary dissections in patients with stage T2-T3 breast tumors. Sherry Boschert of the Global Medical News Network (GMNN) reports from the annual meeting of the American Surgical Association in Indian Wells, Calif. |
 |
Palliative Oxygen vs. Air Posted by: OncologyReport
Video duration: 199 seconds Palliative oxygen was no better than air delivered by nasal cannulae for relieving dyspnea or improving quality of life in a study of 239 non- or mildly hypoxemic patients with terminal illness. Patrice Wendling of GMNN interviews Dr. Amy Abernethy at the annual meeting of the American Academy of Hospice and Palliative Medicine. |
 |
Brachytherapy Posted by: OncologyReport
Video duration: 172 seconds Dr. Juanita Crook discusses the use of brachytherapy as a treatment for penile cancer. Patrice Wendling of the Global Medical News Network (GMNN) reports from the annual Genitourinary Cancers Symposium. |
